Rankings
▼
Calendar
PRGO Q3 2025 Earnings — Perrigo Company plc Revenue & Financial Results | Market Cap Arena
PRGO
Perrigo Company plc
$1B
Q3 2025 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$1.0B
-4.1% YoY
Gross Profit
$377M
36.1% margin
Operating Income
$73M
7.0% margin
Net Income
$8M
0.7% margin
EPS (Diluted)
$0.05
QoQ Revenue Growth
-1.2%
Cash Flow
Operating Cash Flow
$52M
Free Cash Flow
$30M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$10.1B
Total Liabilities
$5.6B
Stockholders' Equity
$4.4B
Cash & Equivalents
$432M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1.0B
$1.1B
-4.1%
Gross Profit
$377M
$404M
-6.8%
Operating Income
$73M
$80M
-9.7%
Net Income
$8M
-$21M
+135.7%
Revenue Segments
Consumer Self-Care Americas
$646M
62%
Consumer Self-Care International
$398M
38%
Geographic Segments
UNITED STATES
$635M
60%
Europe
$384M
37%
Other Geographical Areas
$24M
2%
IRELAND
$9M
1%
← FY 2025
All Quarters
Q4 2025 →